Literature DB >> 20190795

Hematology: Improved outcome for young adult patients with ALL.

Raymond Hutchinson.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20190795     DOI： 10.1038/nrclinonc.2010.14

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.

Authors:  Adriana Balduzzi; Maria Grazia Valsecchi; Cornelio Uderzo; Paola De Lorenzo; Thomas Klingebiel; Christina Peters; Jan Stary; Maria S Felice; Edina Magyarosy; Valentino Conter; Alfred Reiter; Chiara Messina; Helmut Gadner; Martin Schrappe
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.

Authors:  J M de Bont; B van der Holt; A W Dekker; A van der Does-van den Berg; P Sonneveld; R Pieters
Journal:  Leukemia       Date:  2004-12       Impact factor: 11.528

Review 3.  The challenges of clinical trials for adolescents and young adults with cancer.

Authors:  Andrea Ferrari; Michael Montello; Troy Budd; Archie Bleyer
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

Review 4.  Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials.

Authors:  W Archie Bleyer
Journal:  Med Pediatr Oncol       Date:  2002-01

5.  Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.

Authors:  Nicolas Boissel; Marie-Françoise Auclerc; Véronique Lhéritier; Yves Perel; Xavier Thomas; Thierry Leblanc; Philippe Rousselot; Jean-Michel Cayuela; Jean Gabert; Nathalie Fegueux; Christophe Piguet; Françoise Huguet-Rigal; Christian Berthou; Jean-Michel Boiron; Cécile Pautas; Gérard Michel; Denis Fière; Guy Leverger; Hervé Dombret; André Baruchel
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

6.  Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Nita L Seibel; Peter G Steinherz; Harland N Sather; James B Nachman; Cynthia Delaat; Lawrence J Ettinger; David R Freyer; Leonard A Mattano; Caroline A Hastings; Charles M Rubin; Kathy Bertolone; Janet L Franklin; Nyla A Heerema; Torrey L Mitchell; Allan F Pyesmany; Mei K La; Cheryl Edens; Paul S Gaynon
Journal:  Blood       Date:  2007-11-26       Impact factor: 22.113

7.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

Authors:  Wendy Stock; Mei La; Ben Sanford; Clara D Bloomfield; James W Vardiman; Paul Gaynon; Richard A Larson; James Nachman
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113

8.  In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Authors:  Anthony H Goldstone; Susan M Richards; Hillard M Lazarus; Martin S Tallman; Georgina Buck; Adele K Fielding; Alan K Burnett; Raj Chopra; Peter H Wiernik; Letizia Foroni; Elisabeth Paietta; Mark R Litzow; David I Marks; Jill Durrant; Andrew McMillan; Ian M Franklin; Selina Luger; Niculae Ciobanu; Jacob M Rowe
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

9.  Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.

Authors:  James B Nachman; Mei K La; Stephen P Hunger; Nyla A Heerema; Paul S Gaynon; Caroline Hastings; Leonard A Mattano; Harland Sather; Meenakshi Devidas; David R Freyer; Peter G Steinherz; Nita L Seibel
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

10.  Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

Authors:  Josep-María Ribera; Albert Oriol; Miguel-Angel Sanz; Mar Tormo; Pascual Fernández-Abellán; Eloy del Potro; Eugenia Abella; Javier Bueno; Ricardo Parody; Pilar Bastida; Carlos Grande; Inmaculada Heras; Concepción Bethencourt; Evarist Feliu; Juan-José Ortega
Journal:  J Clin Oncol       Date:  2008-04-10       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.